Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Urological Association
2022-07-01
|
| Series: | Investigative and Clinical Urology |
| Online Access: | https://www.icurology.org/pdf/10.4111/icu.20220203 |